Business
Australian Clinical Labs terms: $408.6m IPO at $4 a share – The Australian Financial Review
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
The brokers equities desks sent terms to fund managers on Wednesday morning, and said they would be back with an institutional bookbuild to sell shares and lock in the listing on Tuesday April 27.
Street Talk. Erin Jonasson
The term sheet said Australian Clinical Labs would seek to raise $408.6 million at $4 a share.
The price represented 15-times forecast profit for the 2021 calendar…
-
General10 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News16 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General12 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for
-
Noosa News16 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game